CLINICAL_TRIALS
trial_result
· 2018-10-05
Clinical Trial Update: A Study on Rituximab (MabThera) in Participants With Chronic Lymphocytic Leukemia (CLL)
Summary
Clinical trial update for rituximab in chronic lymphocytic leukemia has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Lymphocytic Leukemia, Chronic | Status: COMPLETED | Results posted: 2018-10-05